Larotrectinib Shows Significant Efficacy in NTRK+ Salivary Gland Tumors
Treatment with larotrectinib (Vitrakvi) in patients with various subtypes of salivary gland tumors led to a high rate early and...
Treatment with larotrectinib (Vitrakvi) in patients with various subtypes of salivary gland tumors led to a high rate early and...